Quarterly report pursuant to Section 13 or 15(d)

Share Holders Equity (Deficit) (Details)

v3.19.3
Share Holders Equity (Deficit) (Details) - Warrants [Member]
6 Months Ended
Jun. 30, 2019
$ / shares
shares
Number of Warrants, Beginning Balance 17,818,844
Number of Warrants, Granted, Series B Preferred Stock 9,262,500
Number of Warrants, Granted, Marathon debt 1,840,275
Number of Warrants, Exercised 0
Number of Warrants, Ending Balance 28,921,619
Weighted Average Exercise Price per Warrant, Beginning Balance | $ / shares $ 1.84
Weighted Average Exercise Price per Warrant, Granted, Series B Preferred Stock | $ / shares 1.62
Weighted Average Exercise Price per Warrant, Granted, Marathon debt | $ / shares 1.40
Weighted Average Exercise Price per Warrant, Ending Balance | $ / shares $ 2.58
Weighted Average Remaining Exercise Term in Months, Beginning Balance 52 months
Weighted Average Remaining Exercise Term in Months, Granted, Series B Preferred Stock 48 months
Weighted Average Remaining Exercise Term in Months, Granted, Marathon debt 60 months
Weighted Average Remaining Exercise Term in Months, Ending Balance 69 months